The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


IFIRMACOMBI



Krka d.d., Novo mestoEU/1/11/673/017-024

Main Information

Trade NameIFIRMACOMBI
Active SubstancesIRBESARTAN HYDROCHLORIDE
HYDROCHLOROTHIAZIDE
Dosage FormFilm-coated tablet
Licence HolderKrka d.d., Novo mesto
Licence NumberEU/1/11/673/017-024

Group Information

ATC CodeC09DA04 irbesartan and diuretics

Status

License statusAuthorised
Licence Issued04/03/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back